{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:40:09Z","timestamp":1793900409841,"version":"4.8.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T00:00:00Z","timestamp":1566172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T00:00:00Z","timestamp":1566172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Eukaryotic translation initiation factor 3 (eIF3) plays an important role in the regulation of mRNA translation, cell growth and cancer development. eIF3b is the main scaffolding subunit in the eIF3 complex and has been demonstrated to contribute to the development of several cancers. First, our study found that the downregulation of eIF3b could inhibit the proliferation and metastasis of gastric cancer cells by regulating the expression of cancer-related genes. In addition, the expression of eIF3b correlated with the stage and progression of gastric cancer and was shown to be upregulated in human chronic gastritis and in gastric cancer tissues compared with the expression of eIF3b in normal gastric tissues. Moreover, <jats:italic>Helicobacter pylori<\/jats:italic> (<jats:italic>H. pylori<\/jats:italic>) infection could upregulate the expression of eIF3b in gastric cancer cells, suggesting that eIF3b might be involved in the carcinogenic process of <jats:italic>H. pylori<\/jats:italic>. The above findings identified the oncogenic role of eIF3b in gastric cancer development, and this may contribute to the exploration and discovery of novel therapeutic targets for gastric cancer treatment.<\/jats:p>","DOI":"10.1038\/s41419-019-1846-0","type":"journal-article","created":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T23:02:41Z","timestamp":1566169361000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Downregulation of eukaryotic translation initiation factor 3b inhibited proliferation and metastasis of gastric cancer"],"prefix":"10.1038","volume":"10","author":[{"given":"Fang","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juchao","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiting","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jichang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yundong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihui","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,19]]},"reference":[{"key":"1846_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394\u2013424 (2018).","journal-title":"CA Cancer J. Clin."},{"key":"1846_CR2","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/nrclinonc.2010.219","volume":"8","author":"MR Sharma","year":"2011","unstructured":"Sharma, M. R. & Schilsky, R. L. GI cancers in 2010: new standards and a predictive biomarker for adjuvant therapy. Nat. Rev. Clin. Oncol. 8, 70\u201372 (2011).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"1846_CR3","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s002689910074","volume":"24","author":"CW Wu","year":"2000","unstructured":"Wu, C. W. et al. Surgical mortality, survival, and quality of life after resection for gastric cancer in the elderly. World J. Surg. 24, 465\u2013472 (2000).","journal-title":"World J. Surg."},{"key":"1846_CR4","doi-asserted-by":"publisher","first-page":"3905","DOI":"10.1245\/s10434-013-3066-7","volume":"20","author":"DH Nam","year":"2013","unstructured":"Nam, D. H. et al. Prognostic value of early postoperative tumor marker response in gastric cancer. Ann. Surg. Oncol. 20, 3905\u20133911 (2013).","journal-title":"Ann. Surg. Oncol."},{"key":"1846_CR5","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.clnu.2012.01.003","volume":"31","author":"L D\u2019Elia","year":"2012","unstructured":"D\u2019Elia, L., Rossi, G., Ippolito, R., Cappuccio, F. P. & Strazzullo, P. Habitual salt intake and risk of gastric cancer: a meta-analysis of prospective studies. Clin. Nutr. 31, 489\u2013498 (2012).","journal-title":"Clin. Nutr."},{"key":"1846_CR6","doi-asserted-by":"publisher","first-page":"4307","DOI":"10.3748\/wjg.v22.i17.4307","volume":"22","author":"M Mihmanli","year":"2016","unstructured":"Mihmanli, M., Ilhan, E., Idiz, U. O., Alemdar, A. & Demir, U. Recent developments and innovations in gastric cancer. World J. Gastroenterol. 22, 4307\u20134320 (2016).","journal-title":"World J. Gastroenterol."},{"key":"1846_CR7","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1038\/nrm1618","volume":"6","author":"M Holcik","year":"2005","unstructured":"Holcik, M. & Sonenberg, N. Translational control in stress and apoptosis. Nat. Rev. Mol. Cell Biol. 6, 318\u2013327 (2005).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1846_CR8","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/nature14267","volume":"522","author":"AS Lee","year":"2015","unstructured":"Lee, A. S., Kranzusch, P. J. & Cate, J. H. eIF3 targets cell-proliferation messenger RNAs for translational activation or repression. Nature 522, 111\u2013114 (2015).","journal-title":"Nature"},{"key":"1846_CR9","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.molcel.2016.05.033","volume":"63","author":"A Simonetti","year":"2016","unstructured":"Simonetti, A. et al. eIF3 peripheral subunits rearrangement after mRNA binding and start-codon recognition. Mol. Cell. 63, 206\u2013217 (2016).","journal-title":"Mol. Cell."},{"key":"1846_CR10","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.tibs.2006.08.005","volume":"31","author":"AG Hinnebusch","year":"2006","unstructured":"Hinnebusch, A. G. eIF3: a versatile scaffold for translation initiation complexes. Trends Biochem Sci. 31, 553\u2013562 (2006).","journal-title":"Trends Biochem Sci."},{"key":"1846_CR11","doi-asserted-by":"publisher","first-page":"10948","DOI":"10.1093\/nar\/gkx805","volume":"45","author":"LS Val\u00e1\u0161ek","year":"2017","unstructured":"Val\u00e1\u0161ek, L. S. et al. Embraced by eIF3: structural and functional insights into the roles of eIF3 across the translation cycle. Nucleic Acids Res. 45, 10948\u201310968 (2017).","journal-title":"Nucleic Acids Res."},{"key":"1846_CR12","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/ijc.20443","volume":"112","author":"G Chen","year":"2004","unstructured":"Chen, G. & Burger, M. M. p150 overexpression in gastric carcinoma: the association with p53, apoptosis and cell proliferation. Int J. Cancer 112, 393\u2013p398 (2004).","journal-title":"Int J. Cancer"},{"key":"1846_CR13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.tice.2018.05.006","volume":"53","author":"X Wang","year":"2018","unstructured":"Wang, X. et al. Eukaryotic translation initiation factor EIF3H potentiates gastric carcinoma cell proliferation. Tissue Cell. 53, 23\u201329 (2018).","journal-title":"Tissue Cell."},{"key":"1846_CR14","doi-asserted-by":"publisher","first-page":"539","DOI":"10.2147\/CMAR.S142324","volume":"9","author":"J He","year":"2017","unstructured":"He, J., Wang, X., Cai, J., Wang, W. & Qin, X. High expression of eIF3d is associated with poor prognosis in patients with gastric cancer. Cancer Manag. Res. 9, 539\u2013544 (2017).","journal-title":"Cancer Manag. Res."},{"key":"1846_CR15","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/cts.12263","volume":"8","author":"Y Cheng","year":"2015","unstructured":"Cheng, Y., Zhou, J. & Li, H. Clinicopathologic implications of eukaryotic initiation factor 3f and Her-2\/neu expression in gastric cancer. Clin. Transl. Sci. 8, 320\u2013325 (2015).","journal-title":"Clin. Transl. Sci."},{"key":"1846_CR16","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1477-7819-12-72","volume":"12","author":"G Li","year":"2014","unstructured":"Li, G., Wang, N., Sun, C. & Li, B. Decreased expression of eukaryotic initiation factor 3f is an adverse prognostic factor for stage I-III gastric cancer. World J. Surg. Oncol. 12, 72 (2014).","journal-title":"World J. Surg. Oncol."},{"key":"1846_CR17","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1159\/000360779","volume":"37","author":"Y Cheng","year":"2014","unstructured":"Cheng, Y., Jia, C., Li, G. & Li, H. Expression of eukaryotic initiation factor 3f is associated with prognosis in gastric carcinomas. Oncol. Res. Treat. 37, 198\u2013202 (2014).","journal-title":"Oncol. Res. Treat."},{"key":"1846_CR18","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nature14891","volume":"525","author":"A des Georges","year":"2015","unstructured":"des Georges, A. et al. Structure of mammalian eIF3 in the context of the 43S preinitiation complex. Nature 525, 491\u2013495 (2015).","journal-title":"Nature"},{"key":"1846_CR19","doi-asserted-by":"publisher","first-page":"10772","DOI":"10.1093\/nar\/gkw972","volume":"44","author":"S Wagner","year":"2016","unstructured":"Wagner, S., Herrmannov\u00e1, A., \u0160ikrov\u00e1, D. & Val\u00e1\u0161ek, L. S. Human eIF3b and eIF3a serve as the nucleation core for the assembly of eIF3 into two interconnected modules: the yeast-like core and the octamer. Nucleic Acids Res. 44, 10772\u201310788 (2016).","journal-title":"Nucleic Acids Res."},{"key":"1846_CR20","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1158\/1078-0432.CCR-12-3084","volume":"19","author":"H Wang","year":"2013","unstructured":"Wang, H. et al. Translation initiation factor eIF3b expression in human cancer and its role in tumor growth and lung colonization. Clin. Cancer Res. 19, 2850\u20132860 (2013).","journal-title":"Clin. Cancer Res."},{"key":"1846_CR21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/1477-7819-10-119","volume":"10","author":"Z Wang","year":"2012","unstructured":"Wang, Z., Chen, J., Sun, J., Cui, Z. & Wu, H. RNA interference-mediated silencing of eukaryotic translation initiation factor 3, subunit B (EIF3B) gene expression inhibits proliferation of colon cancer cells. World J. Surg. Oncol. 10, 119 (2012).","journal-title":"World J. Surg. Oncol."},{"key":"1846_CR22","doi-asserted-by":"crossref","first-page":"43401","DOI":"10.18632\/oncotarget.9726","volume":"7","author":"F Xu","year":"2016","unstructured":"Xu, F. et al. Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating \u03b2-catenin signaling pathway. Oncotarget 7, 43401\u201343411 (2016).","journal-title":"Oncotarget"},{"key":"1846_CR23","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1302\/2046-3758.63.BJR-2016-0151.R2","volume":"6","author":"YJ Choi","year":"2017","unstructured":"Choi, Y. J., Lee, Y. S., Lee, H. W., Shim, D. M. & Seo, S. W. Silencing of translation initiation factor eIF3b promotes apoptosis in osteosarcoma cells. Bone Jt. Res. 6, 186\u2013193 (2017).","journal-title":"Bone Jt. Res."},{"key":"1846_CR24","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.7150\/jca.19594","volume":"8","author":"Y Zang","year":"2017","unstructured":"Zang, Y. et al. Eukaryotic translation initiation factor 3b is both a promising prognostic biomarker and a potential therapeutic target for patients with clear cell renal cell carcinoma. J. Cancer 8, 3049\u20133061 (2017).","journal-title":"J. Cancer"},{"key":"1846_CR25","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.4161\/15384101.2014.947203","volume":"13","author":"H Lv","year":"2014","unstructured":"Lv, H. et al. Epithelial cell-derived periostin functions as a tumor suppressor in gastric cancer through stabilizing p53 and E-cadherin proteins via the Rb\/E2F1\/p14ARF\/Mdm2 signaling pathway. Cell Cycle 13, 2962\u20132974 (2014).","journal-title":"Cell Cycle"},{"key":"1846_CR26","doi-asserted-by":"publisher","first-page":"217","DOI":"10.29252\/ibj.22.4.217","volume":"22","author":"F Molaei","year":"2018","unstructured":"Molaei, F., Forghanifard, M. M., Fahim, Y. & Abbaszadegan, M. R. Molecular signaling in tumorigenesis of gastric cancer. Iran. Biomed. J. 22, 217\u2013230 (2018).","journal-title":"Iran. Biomed. J."},{"key":"1846_CR27","doi-asserted-by":"publisher","first-page":"979","DOI":"10.3748\/wjg.v18.i9.979","volume":"18","author":"WX Kuai","year":"2012","unstructured":"Kuai, W. X. et al. Interleukin-8 associates with adhesion, migration, invasion and chemosensitivity of human gastric cancer cells. World J. Gastroenterol. 18, 979\u2013985 (2012).","journal-title":"World J. Gastroenterol."},{"key":"1846_CR28","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3892\/mmr.2015.3370","volume":"12","author":"W Ji","year":"2015","unstructured":"Ji, W. et al. Role of p53\u03b2 in the inhibition of proliferation of gastric cancer cells expressing wild-type or mutated p53. Mol. Med. Rep. 12, 691\u2013695 (2015).","journal-title":"Mol. Med. Rep."},{"key":"1846_CR29","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.ejmech.2015.03.053","volume":"95","author":"GH Zhang","year":"2015","unstructured":"Zhang, G. H. et al. Distinct novel quinazolinone exhibits selective inhibition in MGC-803 cancer cells by dictating mutant p53 function. Eur. J. Med. Chem. 95, 377\u2013387 (2015).","journal-title":"Eur. J. Med. Chem."},{"key":"1846_CR30","first-page":"79","volume":"9","author":"L Zhang","year":"2015","unstructured":"Zhang, L. et al. Arsenic sulfide, the main component of realgar, a traditional Chinese medicine, induces apoptosis of gastric cancer cells in vitro and in vivo. Drug Des. Devel Ther. 9, 79\u201392 (2015).","journal-title":"Drug Des. Devel Ther."},{"key":"1846_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0034194","volume":"7","author":"F Wen","year":"2012","unstructured":"Wen, F. et al. The tumor suppressive role of eIF3f and its function in translation inhibition and rRNA degradation. PLoS One. 7, e34194 (2012).","journal-title":"PLoS One."},{"key":"1846_CR32","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/mc.20379","volume":"47","author":"A Doldan","year":"2008","unstructured":"Doldan, A. et al. Loss of the eukaryotic initiation factor 3f in pancreatic cancer. Mol. Carcinog. 47, 235\u2013244 (2008).","journal-title":"Mol. Carcinog."},{"key":"1846_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-13-586","volume":"13","author":"LL Eftang","year":"2013","unstructured":"Eftang, L. L. et al. Up-regulation of CLDN1 in gastric cancer is correlated with reduced survival. BMC Cancer 13, 586 (2013).","journal-title":"BMC Cancer"},{"key":"1846_CR34","first-page":"9299","volume":"20","author":"AI Lopes","year":"2014","unstructured":"Lopes, A. I., Vale, F. F. & Oleastro, M. Helicobacter pylori infection\u2014recent developments in diagnosis. World J. Gastroenterol. 20, 9299\u20139313 (2014).","journal-title":"World J. Gastroenterol."},{"key":"1846_CR35","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1615\/JEnvironPatholToxicolOncol.2017024821","volume":"36","author":"F Zheng","year":"2017","unstructured":"Zheng, F. et al. Is it a protective factor of Helicobacter pylori infection in overall survival of all gastric cancer? evidence from meta-analysis. J. Environ. Pathol. Toxicol. Oncol. 36, 309\u2013320 (2017).","journal-title":"J. Environ. Pathol. Toxicol. Oncol."},{"key":"1846_CR36","first-page":"S42","volume":"9","author":"Z Fazeli","year":"2016","unstructured":"Fazeli, Z., Alebouyeh, M., Rezaei Tavirani, M., Azimirad, M. & Yadegar, A. CagA induced interleukin-8 secretion in gastric epithelial cells. Gastroenterol. Hepatol. Bed Bench 9, S42\u2013s46 (2016).","journal-title":"Gastroenterol. Hepatol. Bed Bench"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1846-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1846-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1846-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T17:28:46Z","timestamp":1671211726000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-019-1846-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,19]]},"references-count":36,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,9]]}},"alternative-id":["1846"],"URL":"https:\/\/doi.org\/10.1038\/s41419-019-1846-0","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,19]]},"assertion":[{"value":"2 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"623"}}